Assessing Pharmacokinetics in Liver Disease: Challenges and Future Considerations for Classification of Hepatic Dysfunction and Use of In Silico Methods-MedSci.cn

Assessing Pharmacokinetics in Liver Disease: Challenges and Future Considerations for Classification of Hepatic Dysfunction and Use of In Silico Methods

Sahre, MD; Guinn, D; Ramamoorthy, A; Kim, I; Zhang, XY; Mehta, R; Seo, S; Mehta, M; Gobburu, J; Madabushi, R

Sahre, MD (通讯作者)，US FDA, Ctr Drug Evaluat & Res, Off Clin Pharmacol, Off Translat Sci, 10903 New Hampshire Ave, Silver Spring, MD 20903 USA.

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

Assessing Pharmacokinetics in Liver Disease: Challenges and Future Considerations for Classification of Hepatic Dysfunction and Use of In Silico Methods

科室

工具

服务